Bixiye
QP33-22 MHCP Pharmacy Benefit Exclusion for CarvyktiTM and EnjaymoTM
Taariikhda uu dhaqangalayo Barnaamijka: : Abr 27, 2022
Natiijooyinka Raadinta
Soo bandhiga 1001 - 1010 ee natiijooyinka 4164
Bixiye
QP34-22 Minnesota Senior Health Options (MSHO) Model of Care: Annual Training Requirement Reminder
Taariikhda uu dhaqangalayo Barnaamijka: : Abr 27, 2022
Bixiye
QP35-22 Commercial Pharmacy Benefit Update – Revised Drug-Related Prior Authorization (PA) Requirement Notification – Effective June 14, 2022
Taariikhda uu dhaqangalayo Barnaamijka: : Abr 27, 2022
Bixiye
QP24-22 Join the TruHearing Audiology and Hearing Aid Network
Taariikhda uu dhaqangalayo Barnaamijka: : Abr 13, 2022
Bixiye
QP25-22 Reminder for New to Market Medical Drugs: Medical Drug Evaluation Process List
Taariikhda uu dhaqangalayo Barnaamijka: : Abr 13, 2022
Bixiye
QP26-22 Provider Directory Validation (PDV) Tool
Taariikhda uu dhaqangalayo Barnaamijka: : Abr 13, 2022
Bixiye
QP27-22 MHCP Pharmacy Benefit Exclusion for Fyarro
Taariikhda uu dhaqangalayo Barnaamijka: : Abr 13, 2022
Bixiye
QP28-22 MHCP Pharmacy Benefit Update – New drug-related Prior Authorization (PA) with Quantity Limit ( QL) Criteria: OpzeluraTM (ruxolitnib)
Taariikhda uu dhaqangalayo Barnaamijka: : Abr 13, 2022
Bixiye
QP29-22 MHCP Pharmacy Benefit Update – New drug-related Prior Authorization (PA) with Quantity Limit (QL) Criteria: TavneosTM (avacopan)
Taariikhda uu dhaqangalayo Barnaamijka: : Abr 13, 2022
Bixiye
QP30-22 MHCP Pharmacy Benefit Update – New drug-related Prior Authorization (PA) with Quantity Limit (QL) Criteria: TyrvayaTM (varenicline)
Taariikhda uu dhaqangalayo Barnaamijka: : Abr 13, 2022